KRSNA Diagnostics (Mumbai) Private Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
KRSNAA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Krsnaa Diagnostics (Mumbai) Private Limited, part of the promoter group, has filed a disclosure with the stock exchange under Regulation 31(4) of the SEBI Substantial Acquisition of Shares and Takeovers Regulations, 2011. This regulation requires promoters to disclose any encumbrance (such as pledge, lien, or charge) created on their shares in the listed company. The filing is a routine compliance submission, but the actual details of the encumbrance — whether it is a creation, modification, or invocation of a pledge — are not included in the headline.
The announcement itself is a compliance disclosure and does not indicate any immediate change in shareholding. Investors should look for the full disclosure document to understand the nature and size of the encumbrance, as pledge-related events can affect promoter stake stability and stock sentiment.